샘플 요청 목록

 카트 문의
시장보고서
상품코드
1869910

스마트 주사기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 유통 채널별, 용도별, 기술별, 지역별, 부문 예측(2025-2033년)

Smart Syringes Market Size, Share & Trends Analysis Report By Product (Auto-Disable Syringes, Passive Safety Syringes), By Distribution Channel, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

스마트 주사기 시장 요약

세계의 스마트 주사기 시장 규모는 2024년에 10억 5,000만 달러로 평가되었고, 2033년까지 22억 2,000만 달러에 이를 것으로 예측됩니다.

2025-2033년의 CAGR은 8.7%를 나타낼 전망입니다. 이러한 성장은 특히 바늘 찔림 사고(NSI)와 HIV 및 간염과 같은 혈액 매개 감염의 증가로 인해 환자와 의료 종사자의 안전에 대한 관심이 높아진 데 기인합니다.

정부 주도의 예방접종 캠페인 및 예방접종 계획, 특히 인도의 보편적 예방접종 프로그램(UIP)과 같은 국가에서의 계획은 자동 차단 스마트 주사기에 대한 수요를 가속화했습니다. 또한 미국과 유럽의 규제 기관들은 안전 설계 주사 장치 사용을 의무화하여 의료 시설들이 스마트 주사기 도입을 추진하도록 하고 있습니다. 스마트 주사기는 수축형 바늘이나 자동 차단 장치 같은 안전 설계 기능을 갖추어 우발적 바늘 찔림 사고 위험을 크게 줄입니다. 이는 특히 병원 및 클리닉 의료 종사자들 사이에서 주요 공중 보건 우선 과제가 되었습니다. 예를 들어, 2024년 'International Journal of Surgery Global Health' 잡지의 보고에 따르면 바늘 찔림 사고(NSIs)는 주로 내과 및 외과 부서에서 보고되며 전체 사고의 50% 이상을 차지합니다.

고위험 영역으로는 외상 및 응급실(38%)과 수술실(3%)이 포함됩니다. 바늘 찔림 사고의 주요 원인 중 하나는 당뇨병 환자의 인슐린 투여입니다. 응급 요원, 외과의사, 간호사 등 의료 전문가는 특히 위험에 노출되어 있습니다. 전 세계적으로 간호사의 NSI 유병률은 42.8%, 의사는 46.4%, 간호학생은 45.3%로 추정됩니다. 일반적으로 간호사의 NSI 발생률은 약 41%인 반면, 간호학생의 발생률은 8.7%에서 71%까지 크게 차이가 납니다.

특히 개발도상 지역에서 예방접종 커버리지 확대를 목표로 한 글로벌 이니셔티브는 자동차단 스마트 주사기에 대한 수요를 크게 촉진하고 있습니다. 이 주사기는 일회용으로 설계되어 재사용을 효과적으로 방지하고 백신 안전성을 높입니다. 인도에서는 보편적 예방접종 프로그램(UIP)이 연간 약 2,670만 명의 신생아와 2,900만 명의 임산부를 대상으로 하는 최대 규모의 공중보건 사업 중 하나입니다. 가장 비용 효율적인 보건 개입 중 하나로 인정받는 UIP는 백신으로 예방 가능한 질병으로 인한 5세 미만 사망률을 크게 감소시켰습니다.

HIV, B형 간염(HBV), C형 간염(HCV)과 같은 혈액 매개 감염의 증가하는 발생률은 스마트 주사기 시장의 주요 성장 동력입니다. 주사기와 바늘 재사용을 포함한 안전하지 않은 주사 관행은 특히 개발도상국 및 의료 자원이 제한된 환경에서 이러한 감염 확산의 주요 원인입니다. 자동 차단 및 안전 설계 모델을 포함한 스마트 주사기는 재사용과 우발적 바늘 찔림 사고를 방지하도록 설계되어 전파 위험 감소에 핵심적인 역할을 합니다.

자주 묻는 질문

  • 스마트 주사기 시장 규모는 어떻게 예측되나요?
  • 스마트 주사기 시장의 성장 요인은 무엇인가요?
  • 스마트 주사기의 안전 설계 기능은 무엇인가요?
  • 스마트 주사기 시장에서 고위험 영역은 어디인가요?
  • 스마트 주사기 사용의 주요 대상은 누구인가요?
  • 개발도상 지역에서 스마트 주사기 수요가 증가하는 이유는 무엇인가요?
  • 스마트 주사기가 혈액 매개 감염 확산에 미치는 영향은 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 스마트 주사기 시장의 변수, 동향, 범위

  • 시장 계통 전망
    • 보조 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장 과제 분석
  • 스마트 주사기 시장 분석 툴
    • 업계 분석 - Porter's Five Forces 분석
    • PESTEL 분석

제4장 스마트 시린지 시장 : 제품별 추정 및 동향 분석

  • 부문 대시보드
  • 스마트 주사기 시장 : 제품별 변동 분석과 시장 점유율(2024년 및 2033년)
  • 자동 차단 주사기
  • 패시브 안전 주사기
  • 액티브 안전 주사기

제5장 스마트 주사기 시장 : 용도별 추정 및 동향 분석

  • 부문 대시보드
  • 스마트 주사기 시장 : 용도별 변동 분석과 시장 점유율(2024년 및 2033년)
  • 약물 전달
    • 인슐린
    • 백신
    • 호르몬 요법
    • 항암제
    • 기타
  • 혈액 검체 채취
  • 카테터 주사기 세척
  • 기타 특수 주사

제6장 스마트 주사기 시장 : 유통 채널별 추정 및 동향 분석

  • 부문 대시보드
  • 스마트 주사기 시장 : 유통 채널별 변동 분석과 시장 점유율(2024년 및 2033년)
  • 직접 입찰(정부 및 NGO)
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제7장 스마트 시린지 시장 : 기술별 추정 및 동향 분석

  • 부문 대시보드
  • 스마트 주사기 시장 : 기술별 변동 분석과 시장 점유율(2024년 및 2033년)
  • 바늘 격납식 기술
  • 바늘 실드 기술

제8장 스마트 주사기 시장 : 제품, 용도, 유통 채널, 기술별 지역별 추정 및 동향 분석

  • 지역 전망
  • 스마트 주사기 시장 : 지역별 변동 분석과 시장 점유율(2024년 및 2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제9장 경쟁 구도

  • 시장 진출기업의 분류
  • 주요 기업 프로파일
    • Becton, Dickinson and Company(BD)
    • Hindustan Syringes &Medical Devices(HMD)
    • Terumo Corporation
    • Nipro Corporation
    • Retractable Technologies, Inc.
    • SCHOTT Pharma
    • Schreiner MediPharm
    • Gerresheimer AG
    • SPM Medicare
    • Restek Corporation
    • Shimadzu
    • Trajan LPP
    • Liaoning Kangyi Medical Equipment Co., Ltd
    • AccuPoint(AdvaCare Pharma)
    • Agilent
  • 히트맵 분석/기업시장 포지셔닝 분석
  • 기업의 시장 점유율 예측 분석(2024년)
HBR 25.12.15

Smart Syringes Market Summary

The global smart syringes market size was estimated at USD 1.05 billion in 2024 and is projected to reach USD 2.22 billion by 2033, growing at a CAGR of 8.7% from 2025 to 2033. The growth is attributed to the increasing focus on patient and healthcare worker safety, particularly with the rise in Needle Stick Injuries (NSIs) and the transmission of blood-borne infections such as HIV and hepatitis.

Government-led vaccination drives and immunization initiatives, especially in countries such as India through the Universal Immunization Programme (UIP), have accelerated demand for auto-disable smart syringes. Moreover, regulatory bodies across the U.S. and Europe have mandated the use of safety-engineered injection devices, pushing healthcare facilities toward smart syringe adoption. Smart syringes have safety-engineered features such as retractable needles or auto-disable mechanisms, significantly reducing the risk of accidental needle-stick injuries. This has become a major public health priority, especially among healthcare workers in hospitals and clinics. For Instance, according to a report by International Journal of Surgery Global Health in 2024, Needlestick injuries (NSIs) are predominantly reported in medical and surgical departments, accounting for over 50% of all incidents.

High-risk areas include trauma and emergency rooms (38%) and operating rooms (3%). Among the key products contributing to NSIs, insulin administration in diabetic patients is a significant cause. Healthcare professionals such as emergency personnel, surgeons, and nurses are particularly at risk. Globally, the prevalence of NSIs is estimated at 42.8% among nurses, 46.4% among doctors, and 45.3% among nursing students. In general, NSI rates among nurses are approximately 41%, while nursing student rates vary widely from 8.7% to 71%.

Global initiatives aimed at expanding immunization coverage, particularly in developing regions, are significantly boosting the demand for auto-disable smart syringes. These syringes are designed for single use, effectively preventing reuse and enhancing vaccine safety. In India, the Universal Immunization Programme (UIP) is one of the largest public health efforts, reaching approximately 26.7 million newborns and 29 million pregnant women annually. Recognized as one of the most cost-effective health interventions, the UIP has significantly reduced under-five mortality rates caused by vaccine-preventable diseases.

The rising incidence of blood-borne infections such as HIV, hepatitis B (HBV), and hepatitis C (HCV) is a major driver for the smart syringe market. Unsafe injection practices, including the reuse of syringes and needles, are significant contributors to the spread of these infections, especially in developing and resource-limited healthcare settings. Smart syringes, including auto-disable and safety-engineered models, are designed to prevent reuse and accidental needlestick injuries, thereby playing a critical role in reducing transmission risks.

Global Smart Syringes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global smart syringes market report based on product, application, distribution channel, technology, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Auto-Disable Syringes
  • Active Safety Syringes
  • Passive Safety Syringes
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Delivery
    • Insulin
    • Vaccines
    • Hormonal Therapies
    • Oncology Drugs
    • Others
  • Blood Specimen Collection
  • Catheter Syringe Flushing
  • Other Specialized Injection
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct Tenders (Government & NGOs)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Needle Retractable Technology
  • Needle Shielding Technology
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased Database.
  • 1.5. GVR's Internal Database
  • 1.6. Secondary Sources
  • 1.7. Third Party Perspective
  • 1.8. Primary Research
  • 1.9. Details of Primary Research
  • 1.10. Information or Data Analysis
  • 1.11. Data Analysis Models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity Flow Analysis (Model 1)
    • 1.14.1. Approach 1: Commodity Flow Approach
  • 1.15. Volume Price Analysis (Model 2)
    • 1.15.1. Approach 2: Volume Price Analysis
  • 1.16. List of Secondary Sources
  • 1.17. List of Primary Sources
  • 1.18. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Syringes Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence of Needlestick Injuries (Nsis)
      • 3.2.1.2. Government Immunization Programs
      • 3.2.1.3. Technological Innovations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Smart Syringes
      • 3.2.2.2. Lack of Awareness in Developing Countries
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increased Focus On Safe Injection Practices
      • 3.2.3.2. Rising Demand in Homecare Settings
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Limited Reusability
  • 3.3. Smart Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Smart Syringes Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Smart Syringes Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Auto-Disable Syringes
    • 4.3.1. Auto-Disable Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Passive Safety Syringes
    • 4.4.1. Passive Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Active Safety Syringes
    • 4.5.1. Active Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Smart Syringes Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Smart Syringes Market: Application Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Drug Delivery
    • 5.3.1. Drug Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Insulin
      • 5.3.2.1. Insulin Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Vaccines
      • 5.3.3.1. Vaccines Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.4. Hormonal Therapies
      • 5.3.4.1. Hormonal Therapies Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.5. Oncology Drugs
      • 5.3.5.1. Oncology Drugs Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.4. Blood Specimen Collection
    • 5.4.1. Blood Specimen Collection Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.5. Catheter Syringe Flushing
    • 5.5.1. Catheter Syringe Flushing Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.6. Other Specialized Injection
    • 5.6.1. Other Specialized Injection Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Smart Syringes Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Smart Syringes Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Direct Tenders (Government & NGOs)
    • 6.3.1. Direct Tenders (Government & NGOs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Smart Syringes Market: Technology Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Smart Syringes Market: Technology Movement Analysis & Market Share, 2024 & 2033
  • 7.3. Needle Retractable Technology
    • 7.3.1. Needle Retractable Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Needle Shielding Technology
    • 7.4.1. Needle Shielding Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Smart Syringes Market: Regional Estimates & Trend Analysis by Product, Application, Distribution Channel, Technology

  • 8.1. Regional Outlook
  • 8.2. Smart Syringes Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Scenario
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Mexico Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Denmark Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Sweden Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Japan Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. China Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Argentina Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Reimbursement Scenario
      • 8.7.5.5. Kuwait Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Becton, Dickinson and Company (BD)
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Hindustan Syringes & Medical Devices (HMD)
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Terumo Corporation
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Nipro Corporation
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Retractable Technologies, Inc.
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. SCHOTT Pharma
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Schreiner MediPharm
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Gerresheimer AG
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. SPM Medicare
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Restek Corporation
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives
    • 9.2.11. Shimadzu
      • 9.2.11.1. Company Overview
      • 9.2.11.2. Financial Performance
      • 9.2.11.3. Product Benchmarking
      • 9.2.11.4. Strategic Initiatives
    • 9.2.12. Trajan LPP
      • 9.2.12.1. Company Overview
      • 9.2.12.2. Financial Performance
      • 9.2.12.3. Product Benchmarking
      • 9.2.12.4. Strategic Initiatives
    • 9.2.13. Liaoning Kangyi Medical Equipment Co., Ltd
      • 9.2.13.1. Company Overview
      • 9.2.13.2. Financial Performance
      • 9.2.13.3. Product Benchmarking
      • 9.2.13.4. Strategic Initiatives
    • 9.2.14. AccuPoint (AdvaCare Pharma)
      • 9.2.14.1. Company Overview
      • 9.2.14.2. Financial Performance
      • 9.2.14.3. Product Benchmarking
      • 9.2.14.4. Strategic Initiatives
    • 9.2.15. Agilent
      • 9.2.15.1. Company Overview
      • 9.2.15.2. Financial Performance
      • 9.2.15.3. Product Benchmarking
      • 9.2.15.4. Strategic Initiatives
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Estimated Company Market Share Analysis, 2024
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제